Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Lone Republican becomes only lawmaker to vote against crackdown on human organ trafficking

by admin May 8, 2025
May 8, 2025
Lone Republican becomes only lawmaker to vote against crackdown on human organ trafficking

A bill aimed at cracking down on the Chinese Communist Party (CCP) and its practice of forced organ harvesting passed with overwhelming support on Wednesday – though one House lawmaker voted against it.

Rep. Thomas Massie, R-Ky., was the lone Republican to oppose the Stop Forced Organ Harvesting Act, which passed 406-1.

‘It’s just another example of us trying to stick our nose in another country’s business and write their laws,’ Massie told Fox News Digital after the vote. ‘And at the end of the day, they’re gonna do what they’re gonna do, and it’s just sort of a virtue signal over here.’

Massie, a conservative libertarian, often votes against House bills that weigh in on another country’s affairs.

The Kentucky Republican pointed out that he opposed the legislation when it was up for a vote during a previous Congress.

But his pushback is also notable now given his status as an open critic of Speaker Mike Johnson, R-La., and at times, of President Donald Trump. 

The bill was introduced by Rep. Chris Smith, R-N.J., and would authorize the Secretary of State to deny U.S. passports and visitor visas to people involved in organ trafficking circles.

It would also call for sanctions on entities and individuals found to have participated in the gruesome illicit industry.

U.S. lawmakers have accused China of forced organ harvesting of its ideological opponents, including Falun Gong practitioners and Uyghur Muslims. 

This post appeared first on FOX NEWS

previous post
High Grade Results Continue in Sandstone Drilling
next post
Trump offers to help India, Pakistan amid growing conflict: ‘I want to see them stop’

Related Posts

Schumer to force Senate reading of Trump’s entire...

June 29, 2025

DAVID MARCUS: What the conservative think tank wars...

December 29, 2025

CDC eyes narrower COVID-19 vaccine guidance ahead of...

April 16, 2025

Trump says 80% tariff on China ‘seems right’...

May 10, 2025

Trump to void all documents allegedly signed by...

November 29, 2025

Trump, Putin on same page about Iran’s nuclear...

March 19, 2025

Feds unseal charges against ‘Barbecue,’ Haitian gang leader...

August 13, 2025

GOP holdouts unmoved by Trump’s ‘big, beautiful’ trip...

May 21, 2025

DOJ discovers more than 1M potential Epstein records,...

December 25, 2025

House passes nearly $180B funding package after conservative...

January 9, 2026

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved